Fondaparinux sodium
98%
- Product Code: 74128
CAS:
114870-03-0
Properties:
This product is for scientific research only
| Molecular Weight: | 1728.08 g./mol | Molecular Formula: | C₃₁H₄₃N₃O₄₉S₈₁₀Na |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, inert gas storage |
Product Description:
Fondaparinux sodium is primarily used as an anticoagulant to prevent and treat blood clots. It is commonly administered in patients undergoing major orthopedic surgeries, such as hip or knee replacements, to reduce the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE). It is also used in the treatment of acute DVT and PE, often in combination with other medications. Additionally, it is prescribed for patients with unstable angina or non-ST-segment elevation myocardial infarction (NSTEMI) to prevent thrombotic complications. The drug is administered via subcutaneous injection and is preferred in certain cases due to its predictable pharmacokinetics and reduced need for monitoring compared to other anticoagulants.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to off-white Solid |
| PURITY | 97.5-100 |
| 1 H NMR Spectrum | Consistent with structure |
| TOTAL IMPURITIES | 2.0 |
| ETHANOL | 5000ppm |
| Pyridine | 50ppm |
| WATER | 20.0 |
| PH | 6.0-8.0 |
| basis | 11.5 15.0% |
| Free sulfates | 0.30 |
| Residual chloride | 1.0 |
| Microbial Enumeration | 350CFUg |
| Bacterial endotoxins | 25EUmg |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | Ft68,738.81 |
+
-
|
| 0.025 | 10-20 days | Ft271,830.74 |
+
-
|
| 0.100 | 10-20 days | Ft680,169.44 |
+
-
|
Fondaparinux sodium
Fondaparinux sodium is primarily used as an anticoagulant to prevent and treat blood clots. It is commonly administered in patients undergoing major orthopedic surgeries, such as hip or knee replacements, to reduce the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE). It is also used in the treatment of acute DVT and PE, often in combination with other medications. Additionally, it is prescribed for patients with unstable angina or non-ST-segment elevation myocardial infarction (NSTEMI) to prevent thrombotic complications. The drug is administered via subcutaneous injection and is preferred in certain cases due to its predictable pharmacokinetics and reduced need for monitoring compared to other anticoagulants.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :